• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER®AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER®AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number PLA260300J
Device Problem Device Handling Problem (3265)
Patient Problem Obstruction/Occlusion (2422)
Event Date 04/06/2022
Event Type  Injury  
Event Description
On (b)(6) 2022, this patient underwent an endovascular treatment for an abdominal aortic aneurysm using gore® excluder® aaa endoprostheses.During the procedure, the physician deployed a contralateral leg while pushing it proximally, which resulted proximal movement.The proximal end of contralateral leg was 1 cm more proximal to the level of the long radiopaque marker.A type ia endoleak was found after deployment of trunk-ipsilateral leg endoprosthesis and contralateral leg; therefore, an aortic extender was additionally placed 5 mm proximal to the trunk-ipsilateral leg endoprosthesis.When deploying the aortic extender, the distal end was interfered with the contralateral leg.This caused migration of the aortic extender, and the left renal artery and the right accessory renal artery were unintentionally covered by the stent graft.No blood flow into these arteries was noted.A gore® viabahn® vbx balloon expandable endoprosthesis (7 mm x 29 mm) was additionally implanted in the left renal artery.Blood flow was recovered.The patient tolerated the procedure.
 
Event Description
On (b)(6) 2022, this patient underwent an endovascular treatment for an abdominal aortic aneurysm using gore® excluder® aaa endoprostheses.During the procedure, the physician deployed a contralateral leg while pushing it proximally, which resulted proximal movement.The proximal end of contralateral leg was 1 cm more proximal to the level of the long radiopaque marker.A type ia endoleak was found after deployment of trunk-ipsilateral leg endoprosthesis and contralateral leg; therefore, an aortic extender was additionally placed 5 mm proximal to the trunk-ipsilateral leg endoprosthesis.When deploying the aortic extender, the distal end was interfered with the contralateral leg.This caused migration of the aortic extender, and the left renal artery was unintentionally covered by the stent graft.No blood flow into these arteries was noted.A gore® viabahn® vbx balloon expandable endoprosthesis (7 mm x 29 mm) was additionally implanted in the left renal artery.Blood flow was recovered.The patient tolerated the procedure.
 
Manufacturer Narrative
B5: description of event corrected to indicate that only the left renal artery was unintentionally covered by the stent graft.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER®AAA ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL SILICON VALLEY B/P
2890 de la cruz blvd.
santa clara CA 95050
Manufacturer Contact
douglas rhodes
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key14280899
MDR Text Key290687842
Report Number3013164176-2022-01363
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/23/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberPLA260300J
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/06/2022
Initial Date FDA Received05/04/2022
Supplement Dates Manufacturer Received04/06/2022
Supplement Dates FDA Received06/23/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/19/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
PLC161400J/ (B)(4)
Patient Outcome(s) Required Intervention;
Patient Age86 YR
Patient SexMale
-
-